Patient Experiences After Aborted Cancer Surgery: A Qualitative Study
- PMID: 37540329
- DOI: 10.1245/s10434-023-14046-6
Patient Experiences After Aborted Cancer Surgery: A Qualitative Study
Abstract
Background: Surgical resection is a necessary component of curative-intent treatment for most solid-organ cancers but is occasionally aborted, most often due to occult metastatic disease or unanticipated unresectability. Despite its frequency, little research has been performed on the experiences, care needs, and treatment preferences of patients who experience an aborted cancer surgery.
Methods: Semistructured interviews of patients who had previously experienced an aborted cancer surgery were conducted, focusing on their recalled experiences and stated preferences. All interviews were audio recorded, transcribed, and coded by two independent researchers by using NVivo 12. An integrative approach to qualitative analysis was used-both inductive and deductive methods-and iteratively identifying themes until saturation was reached.
Results: Fifteen patients with an aborted cancer surgery participated in the interviews. Cancer types included pancreatic (n = 9), cholangiocarcinoma (n = 3), hepatocellular carcinoma (n = 1), gallbladder (n = 1), and neuroendocrine (n = 1). The most common reasons for aborting surgery included local tumor unresectability (n = 8) and occult metastatic disease (n = 7). Five subthemes that characterized the patient experience following an aborted cancer surgery emerged, including physical symptoms, emotional responses, impact on social and life factors, coping mechanisms, and support received.
Conclusions: This qualitative study characterizes the impact of aborted cancer surgery on multiple domains of quality of life: physical, emotional, social, and existential. These results highlight the importance of developing patient-centered interventions that focus on enhancing quality of life after aborted cancer surgery.
© 2023. Society of Surgical Oncology.
Comment in
-
ASO Author Reflections: Understanding and Addressing Patient Care Needs after Aborted Cancer Surgery.Ann Surg Oncol. 2023 Dec;30(13):8105-8106. doi: 10.1245/s10434-023-14101-2. Epub 2023 Aug 12. Ann Surg Oncol. 2023. PMID: 37573283 No abstract available.
Similar articles
-
Early Palliative Care Following Aborted Cancer Surgery: Results of a Prospective Feasibility Trial.Ann Surg Open. 2024 Nov 18;5(4):e520. doi: 10.1097/AS9.0000000000000520. eCollection 2024 Dec. Ann Surg Open. 2024. PMID: 39711683 Free PMC article.
-
Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study.World J Gastrointest Oncol. 2022 Jun 15;14(6):1175-1186. doi: 10.4251/wjgo.v14.i6.1175. World J Gastrointest Oncol. 2022. PMID: 35949220 Free PMC article.
-
Outcomes of aborted cancer surgery: a call for patient-centered research.Support Care Cancer. 2022 Mar;30(3):1907-1910. doi: 10.1007/s00520-021-06701-z. Epub 2021 Nov 23. Support Care Cancer. 2022. PMID: 34816329
-
Aborted cancer surgery at a single tertiary cancer center: Rates, reasons, and outcomes.Surgery. 2023 Oct;174(4):880-885. doi: 10.1016/j.surg.2023.06.026. Epub 2023 Jul 22. Surgery. 2023. PMID: 37482440
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
Cited by
-
ASO Author Reflections: Understanding Surgeon Perspectives on the Management of Aborted Cancer Surgery.Ann Surg Oncol. 2024 Apr;31(4):2304-2305. doi: 10.1245/s10434-023-14884-4. Epub 2024 Jan 10. Ann Surg Oncol. 2024. PMID: 38198000 No abstract available.
-
Analysis of aborted bariatric surgeries and potential opportunities.Surg Endosc. 2024 Sep;38(9):5363-5367. doi: 10.1007/s00464-024-11047-8. Epub 2024 Jul 22. Surg Endosc. 2024. PMID: 39039291
-
Early Palliative Care Following Aborted Cancer Surgery: Results of a Prospective Feasibility Trial.Ann Surg Open. 2024 Nov 18;5(4):e520. doi: 10.1097/AS9.0000000000000520. eCollection 2024 Dec. Ann Surg Open. 2024. PMID: 39711683 Free PMC article.
-
Surgeon Perspectives on the Management of Aborted Cancer Surgery: Results of a Society of Surgical Oncology Member Survey.Ann Surg Oncol. 2024 Apr;31(4):2295-2302. doi: 10.1245/s10434-023-14804-6. Epub 2023 Dec 21. Ann Surg Oncol. 2024. PMID: 38127216
-
The Role of Specialty Palliative Care in Elective Surgical Oncology: A Systematic Review.Ann Surg Oncol. 2025 Jun;32(6):3879-3888. doi: 10.1245/s10434-025-17076-4. Epub 2025 Feb 25. Ann Surg Oncol. 2025. PMID: 40000563 Free PMC article.
References
-
- Azari FS, Vollmer CM Jr, Roses RE, et al. A contemporary analysis of palliative procedures in aborted pancreatoduodenectomy: morbidity, mortality, and impact on future therapy. Surgery. 2020;168(6):1026–31. https://doi.org/10.1016/j.surg.2020.06.041 . - DOI - PubMed
-
- Shah MM, Ajay PS, Meltzer RS, et al. The aborted whipple: why, and what happens next? J Surg Oncol. 2022;125(4):642–5. https://doi.org/10.1002/jso.26781 . - DOI - PubMed
-
- Beal EW, Ahmed A, Grotz T, et al. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020;219(3):478–83. https://doi.org/10.1016/j.amjsurg.2019.09.017 . - DOI - PubMed
-
- Guzzo TJ, Rogers CG, Deng CY, et al. Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease. BJU Int. 2008;102(11):1539–43. https://doi.org/10.1111/j.1464-410X.2008.07877.x . - DOI - PubMed
-
- Konstadoulakis MM, Roayaie S, Gomatos IP, et al. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery. 2008;143(3):366–74. https://doi.org/10.1016/j.surg.2007.10.010 . - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical